85431-07-8

Basic information

• Product Name: ethyl 4-(4-hydroxybutyl)benzoate
• Synonyms: ethyl 4-(4-hydroxybutyl)benzoate;methyl 4-(4-hydroxybutyl)benzoate
• CAS NO: 85431-07-8
• Molecular Formula: C₁₃H₁₈O₃
• Molecular Weight: 222.28022
• EINECS: -0
• Mol File: 85431-07-8.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: ethyl 4-(4-hydroxybutyl)benzoate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 4-(4-hydroxybutyl)benzoate(85431-07-8)
• EPA Substance Registry System: ethyl 4-(4-hydroxybutyl)benzoate(85431-07-8)

Safety Data

• Hazardous Substances Data: 85431-07-8(Hazardous Substances Data)

Usage

Description

Ethyl 4-(4-hydroxybutyl)benzoate is an organic compound characterized by the chemical formula C16H22O3. It is derived from benzoic acid and is recognized for its sweet, floral aroma. ethyl 4-(4-hydroxybutyl)benzoate is valued for its skin conditioning properties and is frequently incorporated into personal care products to provide a pleasant scent.

Uses

Used in Personal Care Industry:
Ethyl 4-(4-hydroxybutyl)benzoate is used as a fragrance ingredient for its sweet, floral scent, enhancing the sensory experience of perfumes, lotions, and soaps.
Used in Cosmetic Formulation:
In the cosmetic industry, ethyl 4-(4-hydroxybutyl)benzoate is utilized as a skin conditioning agent, contributing to the texture and feel of various cosmetic products, thereby improving their performance and consumer appeal.
Used in Household Products:
Ethyl 4-(4-hydroxybutyl)benzoate is also employed in household products to impart a pleasant aroma, making the products more enjoyable to use and enhancing the overall consumer experience.

Upstream product

• 51934-41-9 4-iodobenzoic acid ethyl ester 
• 5798-75-4 Ethyl 4-bromobenzoate 
• 36440-86-5 C₁₃H₁₆O₄ 
• 927-74-2 3-Butyn-1-ol 
• 33821-94-2 3-(tetrahydro-2H-pyran-2-yloxy)propyl bromide 
• 64-17-5 ethanol 
• 99-94-5 p-Toluic acid 

Downstream Products

• 72313-37-2 ethyl 4-(3-formylpropyl)benzoate 
• 85430-90-6 4-(9-Acetoxy-5-acetyl-5-tert-butoxycarbonyl-tetradecyl)-benzoic acid ethyl ester 
• 85430-95-1 4-(9-Acetoxy-5-acetyl-tetradecyl)-benzoic acid ethyl ester 
• 85430-87-1 4-(5-tert-Butoxycarbonyl-6-oxo-heptyl)-benzoic acid ethyl ester 
• 85431-14-7 4-(5-Acetyl-9-hydroxy-tetradecyl)-benzoic acid 
• 76865-46-8 ethyl 4-(4-bromobutyl)benzoate 
• 887339-24-4 ethyl 4-[4-(tert-butyldiphenylsilyloxy)-butyl]benzoate 

Relevant articles and documents

Compound as protein degradation agent and preparation method and medical application thereof

The invention discloses a compound serving as a protein degrading agent and a preparation method and medical application thereof, and particularly discloses a compound represented by the formula (I) and a pharmaceutically acceptable salt thereof, and the

1-SUBSTITUTED-3- BETA-D-GLUCOPYRANOSYLATED NITROGENOUS HETERO- CYCLIC COMPOUNDS AND MEDICINES CONTAINING THE SAME

A compound having an SGLT1 and/or SGLT2 inhibitory activity which is usable as an agent for the prevention or treatment of diabetes, postprandial hyperglycemia, impaired glucose tolerance, diabetic complications, obesity, etc. It is a 1-substituted-3-(β-D

11,12-Secoprostaglandins. 6. Interphenylene Analogues of Acylhydroxyalkanoic Acids and Related Compounds as Renal Vasodilators

The synthesis is described of a series of interphenylene analogues of the modified 11,12-secoprostaglandins and their sulfonamide isosteres on which we have reported previously.The new compounds are formally derived from members of earlier series by replacement of segments of the methylene chains by phenylene units.Several of these compounds displayed renal vasodilatory activity on iv stat administration to anesthetized dogs. 4-(4-Acetyl-8-hydroxytridecyl)benzoic acid tested additionally in conscious dogs orally caused a significant increase in renal blood flow at 5 mg/kg.